Index
1 Human Cytomegalovirus Envelope Glycoprotein B Market Overview
1.1 Product Overview and Scope of Human Cytomegalovirus Envelope Glycoprotein B
1.2 Human Cytomegalovirus Envelope Glycoprotein B Segment by Type
1.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Value Comparison by Type (2024-2030)
1.2.2 CSJ-148
1.2.3 CyMVectin
1.2.4 TRL-345
1.2.5 PPCM
1.2.6 Cytomegalovirus Vaccine
1.2.7 Others
1.3 Human Cytomegalovirus Envelope Glycoprotein B Segment by Application
1.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Value by Application: (2024-2030)
1.3.2 Infectious Disease
1.3.3 Oncology
1.3.4 Women's Health
1.3.5 Others
1.4 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Estimates and Forecasts
1.4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue 2019-2030
1.4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales 2019-2030
1.4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Cytomegalovirus Envelope Glycoprotein B Market Competition by Manufacturers
2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Average Price by Manufacturers (2019-2024)
2.4 Global Human Cytomegalovirus Envelope Glycoprotein B Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Product Type & Application
2.7 Human Cytomegalovirus Envelope Glycoprotein B Market Competitive Situation and Trends
2.7.1 Human Cytomegalovirus Envelope Glycoprotein B Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Cytomegalovirus Envelope Glycoprotein B Players Market Share by Revenue
2.7.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Cytomegalovirus Envelope Glycoprotein B Retrospective Market Scenario by Region
3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region: 2019-2030
3.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region: 2019-2024
3.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region: 2025-2030
3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region: 2019-2030
3.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region: 2019-2024
3.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region: 2025-2030
3.4 North America Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Country
3.4.1 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2030)
3.4.3 North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Country
3.5.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2030)
3.5.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Country
3.6.1 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Country
3.7.1 Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2030)
3.7.3 Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2019-2030)
4.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2019-2024)
4.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2025-2030)
4.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2019-2030)
4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2019-2030)
4.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2019-2024)
4.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2025-2030)
4.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2019-2030)
4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2019-2030)
5.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2019-2024)
5.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2025-2030)
5.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2019-2030)
5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2019-2030)
5.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2019-2024)
5.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2025-2030)
5.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2019-2030)
5.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Astellas Pharma Inc.
6.1.1 Astellas Pharma Inc. Corporation Information
6.1.2 Astellas Pharma Inc. Description and Business Overview
6.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
6.1.5 Astellas Pharma Inc. Recent Developments/Updates
6.2 Trellis Bioscience, Inc.
6.2.1 Trellis Bioscience, Inc. Corporation Information
6.2.2 Trellis Bioscience, Inc. Description and Business Overview
6.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
6.2.5 Trellis Bioscience, Inc. Recent Developments/Updates
6.3 Vakzine Projekt Management GmbH
6.3.1 Vakzine Projekt Management GmbH Corporation Information
6.3.2 Vakzine Projekt Management GmbH Description and Business Overview
6.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
6.3.5 Vakzine Projekt Management GmbH Recent Developments/Updates
6.4 VBI Vaccine Inc
6.4.1 VBI Vaccine Inc Corporation Information
6.4.2 VBI Vaccine Inc Description and Business Overview
6.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2019-2024)
6.4.4 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
6.4.5 VBI Vaccine Inc Recent Developments/Updates
6.5 Vical Incorporated
6.5.1 Vical Incorporated Corporation Information
6.5.2 Vical Incorporated Description and Business Overview
6.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
6.5.5 Vical Incorporated Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Cytomegalovirus Envelope Glycoprotein B Industry Chain Analysis
7.2 Human Cytomegalovirus Envelope Glycoprotein B Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Cytomegalovirus Envelope Glycoprotein B Production Mode & Process
7.4 Human Cytomegalovirus Envelope Glycoprotein B Sales and Marketing
7.4.1 Human Cytomegalovirus Envelope Glycoprotein B Sales Channels
7.4.2 Human Cytomegalovirus Envelope Glycoprotein B Distributors
7.5 Human Cytomegalovirus Envelope Glycoprotein B Customers
8 Human Cytomegalovirus Envelope Glycoprotein B Market Dynamics
8.1 Human Cytomegalovirus Envelope Glycoprotein B Industry Trends
8.2 Human Cytomegalovirus Envelope Glycoprotein B Market Drivers
8.3 Human Cytomegalovirus Envelope Glycoprotein B Market Challenges
8.4 Human Cytomegalovirus Envelope Glycoprotein B Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer